Evidence That Aβ42 Plasma Levels in Presenilin-1 Mutation Carriers Do not Allow for Prediction of Their Clinical Phenotype

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neurobiology of Disease

• Publication date

  1999-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/NBDI.1999.0247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins.

  1998cited by this paper
• A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease.

  1998cited by this paper
• Presenilin mutations in Alzheimer's disease

  1998cited by this paper
• Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein

  1998cited by this paper
• Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain.

  1998cited by this paper
• Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.

  1998cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Increased Aβ42(43) from cell lines expressing presenilin 1 mutations

  1998cited by this paper
• Mutant Presenilin 2 Transgenic Mouse: Effect on an Age‐Dependent Increase of Amyloid β‐Protein 42 in the Brain

  1998cited by this paper
• Amyloid (Aβ) deposition in chromosome 1–linked Alzheimer's disease: The volga german families

  1997cited by this paper
• Processing of presenilin 1 in brains of patients with Alzheimer's disease and controls

  1997cited by this paper
• Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins*

  1997cited by this paper
• Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

  1997cited by this paper
• Increased A beta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene.

  1997cited by this paper
• A novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes

  1997cited by this paper
• Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

  1997cited by this paper
• Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43)

  1996cited by this paper
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

  1996cited by this paper
• Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo.

  1996cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells

  1996cited by this paper
• Diffuse Plaques in the Cerebellum and Corpus Striatum in Down's Syndrome Contain Amyloid β Protein (Aβ) only in the Form of Aβ42(43)

  1996cited by this paper
• The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families

  1995cited by this paper
• High levels of amyloid-beta protein from S182 (Glu246) familial Alzheimer's cells.

  1995cited by this paper
• Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3.

  1995cited by this paper
• A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene

  1995cited by this paper
• Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain

  1995cited by this paper
• Alzheimer's Disease: A Central Role for Amyloid

  1994cited by this paper
• Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

  1994cited by this paper
• APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease.

  1994cited by this paper
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

  1994cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Apolipoprotein E genotyping by one-stage PCR.

  1991cited by this paper
• Early‐onset Alzheimer's disease in 2 large Belgian families

  1991cited by this paper

• Novel Association of the Presenilin-1 (Leu282Arg) Mutation with Isolated Spastic Paraparesis: Case Presentation and Review of Current Evidence

  2025cites this paper
• Both positional and chemical variables control in vitro proteolytic cleavage of a presenilin ortholog

  2018cites this paper
• Is Sleep Disruption a Risk Factor for Alzheimer’s Disease?

  2017cites this paper
• Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease

  2016cites this paper
• Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis.

  2014cites this paper
• Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases.

  2013cites this paper
• Genetic animal models of cerebral vasculopathies.

  2012cites this paper
• Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.

  2011cites this paper
• Pathological Validation of Animal Models of Dementia

  2011cites this paper
• Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents.

  2010cites this paper
• Requirement for small side chain residues within the GxGD‐motif of presenilin for γ‐secretase substrate cleavage

  2010cites this paper
• Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

  2009cites this paper
• Enhancement of Activation of Caspases by Presenilin 1 Gene Mutations and its Inhibition by Secretase Inhibitors

  2009cites this paper
• Featured Articles Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

  2009cites this paper
• High Serum Aβ and Vascular Risk Factors in First-Degree Relatives of Alzheimer’s Disease Patients

  2009cites this paper
• Biochemical markers in persons with preclinical familial Alzheimer disease

  2008cites this paper
• Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1.

  2007cites this paper
• BACE1 and Mutated Presenilin-1 Differently Modulate Aβ40 and Aβ42 Levels and Cerebral Amyloidosis in APPDutch Transgenic Mice

  2007influential citation
• functionofPS1,indicatingthattheobservedeffectsarediseasespecific.Ourobservationsareconsistentwith thepotentialroleofdisturbedCa 2+ homeostasisinAlzheimerdiseasepathogenesis.

  2007cites this paper
• Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models

  2006cites this paper
• Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin–1 gene

  2006cites this paper
• Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations.

  2004cites this paper
• Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis

  2004cites this paper
• Cerebral Amyloid Angiopathy: New Insights from Transgenic Mice

  2004cites this paper
• A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaques

  2004cites this paper
• Hereditary cerebral hemorrhage with amyloidosis Dutch type (AbetaPP 693): decreased plasma amyloid-beta 42 concentration.

  2003cites this paper
• Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions.

  2003cites this paper
• Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse

  2003cites this paper
• FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction

  2002cites this paper
• Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.

  2002cites this paper
• Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production

  2002cites this paper
• Identification of the tumor metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome.

  2001cites this paper
• The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer’s Disease, Reflecting a Common Pathophysiological Process

  2001cites this paper
• α2-Macroglobulin-Mediated Degradation of Amyloid β1–42: A Mechanism to Enhance Amyloid β Catabolism

  2001cites this paper
• Human Nck-associated protein 1 and its binding protein affect the metabolism of beta-amyloid precursor protein with Swedish mutation.

  2001cites this paper
• Biological Markers for Alzheimer's Disease

  2001cites this paper
• Pathogenic APP mutations near the γ-secretase cleavage site differentially affect Aβ secretion and APP C-terminal fragment stability

  2001cites this paper
• Intramembrane proteolysis by presenilins

  2000cites this paper
• Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases

  2000cites this paper
• Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS‐1 mutations that lead to exceptionally high amyloid‐β concentrations

  2000cites this paper
• Molecular Medicine Original Articles Evidence That the ␤-catenin Nuclear Translocation Assay Allows for Measuring Presenilin 1 Dysfunction

  2000cites this paper
• Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma

  2000cites this paper
• Proteolytic processing of presenilin-1 in human lymphoblasts is not affected by the presence of the I143T and G384A mutations.

  1999cites this paper
• Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion.

  1999cites this paper
• Alzheimer's disease associated presenilin 1 interacts with HC5 and ZETA, subunits of the catalytic 20S proteasome.

  1999cites this paper
• No influence of presenilin1 I143T and G384A mutations on endogenous tau phosphorylation in human and mouse neuroblastoma cells.

  1999cites this paper